|
1
|
Aflorei ED and Korbonits M: Epidemiology
and etiopathogenesis of pituitary adenomas. J Neurooncol.
117:379–394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kovacs K, Horvath E, Ryan N and Ezrin C:
Null cell adenoma of the human pituitary. Virchows Arch A Pathol
Anat Histol. 387:165–174. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saeger W, Lüdecke DK, Buchfelder M,
Fahlbusch R, Quabbe HJ and Petersenn S: Pathohistological
classification of pituitary tumors: 10 years of experience with the
German Pituitary Tumor Registry. Eur J Endocrinol. 156:203–216.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng GXY, Do BT, Webster DE, Khavari PA
and Chang HY: Dicer-microRNA-Myc circuit promotes transcription of
hundreds of long noncoding RNAs. Nat Struct Mol Biol. 21:585–590.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo S, Lu JY, Liu L, Yin Y, Chen C, Han X,
Wu B, Xu R, Liu W, Yan P, et al: Divergent lncRNAs regulate gene
expression and lineage differentiation in pluripotent cells. Cell
Stem Cell. 18:637–652. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li L, Liu B, Wapinski OL, Tsai MC, Qu K,
Zhang J, Carlson JC, Lin M, Fang F, Gupta RA, et al: Targeted
disruption of Hotair leads to homeotic transformation and gene
derepression. Cell Rep. 5:3–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chunharojrith P, Nakayama Y, Jiang X, Kery
RE, Ma J, De La Hoz Ulloa CS, Zhang X, Zhou Y and Klibanski A:
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived
cell line. Mol Cell Endocrinol. 416:27–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Li C, Liu C, Yu S and Zhang Y:
Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in
non-functioning pituitary adenomas and their relationship to tumor
behavior. Pituitary. 18:42–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang ZY, Lu YX, Zhang ZY, Chang YY, Zheng
L, Yuan L, Zhang F, Hu YH, Zhang WJ and Li XN: Loss of TINCR
expression promotes proliferation, metastasis through activating
EpCAM cleavage in colorectal cancer. Oncotarget. 7:22639–22649.
2016.PubMed/NCBI
|
|
12
|
Wei G, Luo H, Sun Y, Li J, Tian L, Liu W,
Liu L, Luo J, He J and Chen R: Transcriptome profiling of
esophageal squamous cell carcinoma reveals a long noncoding RNA
acting as a tumor suppressor. Oncotarget. 6:17065–17080. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee S, Kopp F, Chang T-C, Sataluri A, Chen
B, Sivakumar S, Yu H, Xie Y and Mendell JT: Noncoding RNA NORAD
regulates genomic stability by sequestering PUMILIO proteins. Cell.
164:69–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H, Li J, Koirala P, Ding X, Chen B,
Wang Y, Wang Z, Wang C, Zhang X and Mo YY: Long non-coding RNAs as
prognostic markers in human breast cancer. Oncotarget.
7:20584–20596. 2016.PubMed/NCBI
|
|
15
|
Lloyd R, Kovacs K, Young WJ, et al: Tumour
of the pituitary gland. World Health Organization Classification of
Tumours: Pathology and Genetics of Tumours of Endocrine Organs.
Delellis RA, Lloyd RV, Heitz PU and Eng C: Lyon: International
Agency for Research and Cancer (IARC) Press; pp. 9–48. 2004
|
|
16
|
Wilson CB: A decade of pituitary
microsurgery. The Herbert Olivecrona lecture. J Neurosurg.
61:814–833. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Knosp E, Steiner E, Kitz K and Matula C:
Pituitary adenomas with invasion of the cavernous sinus space: A
magnetic resonance imaging classification compared with surgical
findings. Neurosurgery. 33:610–617; discussion 617–618. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Micko ASG, Wöhrer A, Wolfsberger S and
Knosp E: Invasion of the cavernous sinus space in pituitary
adenomas: Endoscopic verification and its correlation with an
MRI-based classification. J Neurosurg. 122:803–811. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin XC, Zhu Y, Chen WB, Lin LW, Chen DH,
Huang JR, Pan K, Lin Y, Wu BT, Dai Y, et al: Integrated analysis of
long non-coding RNAs and mRNA expression profiles reveals the
potential role of lncRNAs in gastric cancer pathogenesis. Int J
Oncol. 45:619–628. 2014.PubMed/NCBI
|
|
21
|
Jia H, Osak M, Bogu GK, Stanton LW,
Johnson R and Lipovich L: Genome-wide computational identification
and manual annotation of human long noncoding RNA genes. RNA.
16:1478–1487. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tafer H and Hofacker IL: RNAplex: A fast
tool for RNA-RNA interaction search. Bioinformatics. 24:2657–2663.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tafer H, Amman F, Eggenhofer F, Stadler PF
and Hofacker IL: Fast accessibility-based prediction of RNA-RNA
interactions. Bioinformatics. 27:1934–1940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kontogeorgos G and Thodou E: The
gonadotroph origin of null cell adenomas. Hormones (Athens).
15:243–247. 2016.PubMed/NCBI
|
|
25
|
Ishii Y, Suzuki M, Takekoshi S, Egashira
N, Yamazaki M, Miyai S, Sanno N, Teramoto A and Osamura RY:
Immunonegative ‘null cell’ adenomas and gonadotropin (Gn) subunit
(SUs) immunopositive adenomas share frequent expression of multiple
transcription factors. Endocr Pathol. 17:35–43. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balogun JA, Monsalves E, Juraschka K,
Parvez K, Kucharczyk W, Mete O, Gentili F and Zadeh G: Null cell
adenomas of the pituitary gland: An institutional review of their
clinical imaging and behavioral characteristics. Endocr Pathol.
26:63–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu YP, Bian XJ, Ye DW, Yao XD, Zhang SL,
Dai B, Zhang HL and Shen YJ: Long noncoding RNA expression
signatures of bladder cancer revealed by microarray. Oncol Lett.
7:1197–1202. 2014.PubMed/NCBI
|
|
28
|
Tremblay JJ, Lanctôt C and Drouin J: The
pan-pituitary activator of transcription, Ptx1 (pituitary homeobox
1), acts in synergy with SF-1 and Pit1 and is an upstream regulator
of the Lim-homeodomain gene Lim3/Lhx3. Mol Endocrinol. 12:428–441.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kolfschoten IGM, van Leeuwen B, Berns K,
Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM and Agami
R: A genetic screen identifies PITX1 as a suppressor of RAS
activity and tumorigenicity. Cell. 121:849–858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamolet B, Pulichino AM, Lamonerie T,
Gauthier Y, Brue T, Enjalbert A and Drouin J: A pituitary
cell-restricted T box factor, Tpit, activates POMC transcription in
cooperation with Pitx homeoproteins. Cell. 104:849–859. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pellegrini-Bouiller I, Manrique C, Gunz G,
Grino M, Zamora AJ, Figarella-Branger D, Grisoli F, Jaquet P and
Enjalbert A: Expression of the members of the Ptx family of
transcription factors in human pituitary adenomas. J Clin
Endocrinol Metab. 84:2212–2220. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wierinckx A, Auger C, Devauchelle P,
Reynaud A, Chevallier P, Jan M, Perrin G, Fèvre-Montange M, Rey C,
Figarella-Branger D, et al: A diagnostic marker set for invasion,
proliferation, and aggressiveness of prolactin pituitary tumors.
Endocr Relat Cancer. 14:887–900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qian ZR, Sano T, Yoshimoto K, Yamada S,
Ishizuka A, Mizusawa N, Horiguchi H, Hirokawa M and Asa SL:
Inactivation of RASSF1A tumor suppressor gene by aberrant promoter
hypermethylation in human pituitary adenomas. Lab Invest.
85:464–473. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pefani D-E, Latusek R, Pires I, Grawenda
AM, Yee KS, Hamilton G, van der Weyden L, Esashi F, Hammond EM and
O'Neill E: RASSF1A-LATS1 signalling stabilizes replication forks by
restricting CDK2-mediated phosphorylation of BRCA2. Nat Cell Biol.
16:962–971, 1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang KH, Huang SF, Chen I-H, Liao CT,
Wang HM and Hsieh LL: Methylation of RASSF1A, RASSF2A, and HIN-1 is
associated with poor outcome after radiotherapy, but not surgery,
in oral squamous cell carcinoma. Clin Cancer Res. 15:4174–4180.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krop I, Parker MT, Bloushtain-Qimron N,
Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R and
Polyak K: HIN-1, an inhibitor of cell growth, invasion, and AKT
activation. Cancer Res. 65:9659–9669. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shigematsu H, Suzuki M, Takahashi T,
Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D,
Pass HI, Brambilla E, et al: Aberrant methylation of HIN-1 (high in
normal-1) is a frequent event in many human malignancies. Int J
Cancer. 113:600–604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ladha J, Sinha S, Bhat V, Donakonda S and
Rao SM: Identification of genomic targets of transcription factor
AEBP1 and its role in survival of glioma cells. Mol Cancer Res.
10:1039–1051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou Y, Zhang X and Klibanski A: Genetic
and epigenetic mutations of tumor suppressive genes in sporadic
pituitary adenoma. Mol Cell Endocrinol. 386:16–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sleiter N, Pang Y, Park C, Horton TH, Dong
J, Thomas P and Levine JE: Progesterone receptor A (PRA) and
PRB-independent effects of progesterone on gonadotropin-releasing
hormone release. Endocrinology. 150:3833–3844. 2009. View Article : Google Scholar : PubMed/NCBI
|
